- Home
- GROV vs CALC Comparison
GROV vs CALC Comparison
Compare GROV & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROV
- CALC
- Stock Information
- Founded
- GROV 2016
- CALC 2011
- Country
- GROV United States
- CALC United States
- Employees
- GROV N/A
- CALC N/A
- Industry
- GROV Package Goods/Cosmetics
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- GROV Consumer Discretionary
- CALC Health Care
- Exchange
- GROV Nasdaq
- CALC Nasdaq
- Market Cap
- GROV 59.0M
- CALC 40.3M
- IPO Year
- GROV N/A
- CALC N/A
- Fundamental
- Price
- GROV $1.40
- CALC $2.76
- Analyst Decision
- GROV Buy
- CALC Strong Buy
- Analyst Count
- GROV 1
- CALC 5
- Target Price
- GROV $2.00
- CALC $18.20
- AVG Volume (30 Days)
- GROV 159.2K
- CALC 70.6K
- Earning Date
- GROV 11-12-2024
- CALC 11-13-2024
- Dividend Yield
- GROV N/A
- CALC N/A
- EPS Growth
- GROV N/A
- CALC N/A
- EPS
- GROV N/A
- CALC N/A
- Revenue
- GROV $213,781,000.00
- CALC N/A
- Revenue This Year
- GROV N/A
- CALC N/A
- Revenue Next Year
- GROV $0.84
- CALC N/A
- P/E Ratio
- GROV N/A
- CALC N/A
- Revenue Growth
- GROV N/A
- CALC N/A
- 52 Week Low
- GROV $1.19
- CALC $2.05
- 52 Week High
- GROV $2.44
- CALC $8.38
- Technical
- Relative Strength Index (RSI)
- GROV 47.22
- CALC 34.02
- Support Level
- GROV $1.30
- CALC $2.67
- Resistance Level
- GROV $1.56
- CALC $2.90
- Average True Range (ATR)
- GROV 0.08
- CALC 0.26
- MACD
- GROV -0.02
- CALC 0.00
- Stochastic Oscillator
- GROV 37.88
- CALC 50.35
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.